Two other anti-MMP9 monoclonal antibodies, B0041, which targets human MMP9, and B0046, which inhibits stroma-derived mouse MMP9, were found to be highly effective in a HCT 116 mouse colorectal cancer (CC) xenograft model. This evidence concerns the gene MMP9 and colorectal cancer.